Literature DB >> 26206873

Benefits of physical activity on COPD hospitalisation depend on intensity.

David Donaire-Gonzalez1, Elena Gimeno-Santos2, Eva Balcells3, Jordi de Batlle4, Maria A Ramon5, Esther Rodriguez5, Eva Farrero6, Marta Benet2, Stefano Guerra7, Jaume Sauleda8, Antoni Ferrer9, Jaume Ferrer5, Joan A Barberà10, Robert Rodriguez-Roisin10, Joaquim Gea3, Alvar Agustí10, Josep M Antó11, Judith Garcia-Aymerich12.   

Abstract

The present study aims to disentangle the independent effects of the quantity and the intensity of physical activity on the risk reduction of chronic obstructive pulmonary disease (COPD) hospitalisations.177 patients from the Phenotype Characterization and Course of COPD (PAC-COPD) cohort (mean±sd age 71±8 years, forced expiratory volume in 1 s 52±16% predicted) wore the SenseWear Pro 2 Armband accelerometer (BodyMedia, Pittsburgh, PA, USA) for eight consecutive days, providing data on quantity (steps per day, physically active days and daily active time) and intensity (average metabolic equivalent tasks) of physical activity. Information on COPD hospitalisations during follow-up (2.5±0.8 years) was obtained from validated centralised datasets. During follow-up 67 (38%) patients were hospitalised. There was an interaction between quantity and intensity of physical activity in their effects on COPD hospitalisation risk. After adjusting for potential confounders in the Cox regression model, the risk of COPD hospitalisation was reduced by 20% (hazard ratio (HR) 0.79, 95% CI 0.67-0.93; p=0.005) for every additional 1000 daily steps at low average intensity. A greater quantity of daily steps at high average intensity did not influence the risk of COPD hospitalisations (HR 1.01, p=0.919). Similar results were found for the other measures of quantity of physical activity. Greater quantity of low-intensity physical activity reduces the risk of COPD hospitalisation, but high-intensity physical activity does not produce any risk reduction.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26206873     DOI: 10.1183/13993003.01699-2014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Promoting physical activity in COPD: Insights from a randomized trial of a web-based intervention and pedometer use.

Authors:  Emily S Wan; Ana Kantorowski; Diana Homsy; Merilee Teylan; Reema Kadri; Caroline R Richardson; David R Gagnon; Eric Garshick; Marilyn L Moy
Journal:  Respir Med       Date:  2017-07-25       Impact factor: 3.415

2.  Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease.

Authors:  Mon S Bryant; Venkata D Bandi; Christina K Nguyen; Charlie Lan; Helene K Henson; Amir Sharafkhaneh
Journal:  Fed Pract       Date:  2019-09

3.  Physical Activity Patterns in Frail and Nonfrail Patients With End-Stage Liver Disease.

Authors:  Shirley Handelzalts; Michael Volk; Jessica D Zendler; Cristine Agresta; Jillian Peacock; Neil B Alexander
Journal:  J Clin Exp Hepatol       Date:  2021-10-23

4.  Percent Emphysema and Daily Motor Activity Levels in the General Population: Multi-Ethnic Study of Atherosclerosis.

Authors:  Christian M Lo Cascio; Mirja Quante; Eric A Hoffman; Alain G Bertoni; Carrie P Aaron; Joseph E Schwartz; Mark V Avdalovic; Vincent S Fan; Gina S Lovasi; Steven M Kawut; John H M Austin; Susan Redline; R Graham Barr
Journal:  Chest       Date:  2016-12-06       Impact factor: 9.410

5.  Home-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary Outcomes.

Authors:  David B Coultas; Bradford E Jackson; Rennie Russo; Jennifer Peoples; Karan P Singh; John Sloan; Minyong Uhm; Jamile A Ashmore; Steven N Blair; Sejong Bae
Journal:  Ann Am Thorac Soc       Date:  2018-04

6.  Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).

Authors:  Henrik Watz; Claudia Mailänder; Monika Baier; Anne Kirsten
Journal:  BMC Pulm Med       Date:  2016-06-14       Impact factor: 3.317

7.  Effect of counselling during pulmonary rehabilitation on self-determined motivation towards physical activity in people with chronic obstructive pulmonary disease - protocol of a mixed methods study.

Authors:  Anne-Kathrin Rausch-Osthoff; Nicola Greco; Ariane Schwank; Swantje Beyer; David Gisi; Mandy Scheermesser; André Meichtry; Noriane Sievi; Thomas Hess; Markus Wirz
Journal:  BMC Pulm Med       Date:  2017-08-17       Impact factor: 3.317

8.  Common Mental Disorders, Functional Limitation and Diet Quality Trends and Related Factors among COPD Patients in Spain, 2006-2017: Evidence from Spanish National Health Surveys.

Authors:  Silvia Portero de la Cruz; Jesús Cebrino
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

9.  The Minimal Important Difference in Physical Activity in Patients with COPD.

Authors:  Heleen Demeyer; Chris Burtin; Miek Hornikx; Carlos Augusto Camillo; Hans Van Remoortel; Daniel Langer; Wim Janssens; Thierry Troosters
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

10.  Long-Term Effects of an Internet-Mediated Pedometer-Based Walking Program for Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.

Authors:  Marilyn L Moy; Carlos H Martinez; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; Huong Q Nguyen; Miriam D Cohen; David E Goodrich; Nicholas D Giardino; Caroline R Richardson
Journal:  J Med Internet Res       Date:  2016-08-08       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.